Landscapes / Companies
Immunomic Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 1
Drugs
2
in active trials · 4 in all
Trials
2 active
4 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | Feb 2028Phase 1 trial completes | |||
| Next date | Feb 2028 · Phase 1 trial completes | ||||
| Also tested for | Triple Negative Breast Cancer (TNBC) | ||||
| Open drug page | |||||
— |
Phase 1 | Feb 2028Phase 1 trial completes | |||
| Next date | Feb 2028 · Phase 1 trial completes | ||||
| Also tested for | Allergen Immunotherapy | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 Industry-sponsored drug trials since 2021